Log in to save to my catalogue

Corosolic acid inhibits cancer progression by decreasing the level of CDK19-mediated O-GlcNAcylation...

Corosolic acid inhibits cancer progression by decreasing the level of CDK19-mediated O-GlcNAcylation...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0083844afa564fab8f6382bf389cefee

Corosolic acid inhibits cancer progression by decreasing the level of CDK19-mediated O-GlcNAcylation in liver cancer cells

About this item

Full title

Corosolic acid inhibits cancer progression by decreasing the level of CDK19-mediated O-GlcNAcylation in liver cancer cells

Publisher

London: Nature Publishing Group UK

Journal title

Cell death & disease, 2021-09, Vol.12 (10), p.889-11, Article 889

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Diabetes is an important risk factor for liver cancer, but its mechanism is unknown. Corosolic acid (CA) has been proven to have both hypoglycemic and antitumor effects, so revealing the function of CA can help us understand the relationship between diabetes and liver cancer. In previous studies, we confirmed that CA can effectively inhibit the exp...

Alternative Titles

Full title

Corosolic acid inhibits cancer progression by decreasing the level of CDK19-mediated O-GlcNAcylation in liver cancer cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_0083844afa564fab8f6382bf389cefee

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0083844afa564fab8f6382bf389cefee

Other Identifiers

ISSN

2041-4889

E-ISSN

2041-4889

DOI

10.1038/s41419-021-04164-y

How to access this item